Literature DB >> 18608447

Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.

Carolyn A Day1, Libby Topp, Jenny Iversen, Lisa Maher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18608447     DOI： 10.1080/09595230801956132

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN： 0959-5236


× No keyword cloud information.
  3 in total

1.  Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.

Authors:  V D Hope; J McVeigh; A Marongiu; M Evans-Brown; J Smith; A Kimergård; J V Parry; F Ncube
Journal:  Epidemiol Infect       Date:  2014-04-08       Impact factor: 4.434

2.  Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.

Authors:  Vivian D Hope; Jim McVeigh; Andrea Marongiu; Michael Evans-Brown; Josie Smith; Andreas Kimergård; Sara Croxford; Caryl M Beynon; John V Parry; Mark A Bellis; Fortune Ncube
Journal:  BMJ Open       Date:  2013-09-12       Impact factor: 2.692

3.  Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.

Authors:  Vivian D Hope; Ross Harris; Jim McVeigh; Katelyn J Cullen; Josie Smith; John V Parry; Daniela DeAngelis; Fortune Ncube
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.